Erik Lium
Directeur/Membre du Conseil chez RENALYTIX PLC
Profil
Erik Lium is the founder of LabVelocity, which was founded in 1999.
He held the title of President at LabVelocity from 1999 to 2004.
Dr. Lium's current job(s) include Chairman at Kantaro Biosciences LLC, Non-Executive Director at Verici Dx Plc, Non-Executive Director at Trellus Health Plc, Director at ELWC Enterprises Ltd., Director at CastleVax, Inc., Independent Non-Executive Director at Renalytix Plc, Chief Commercial Innovation Officer & Executive VP at The Mount Sinai Health System, Inc., Investment Review Committee Member at Accelerate Long Island (Venture Capital), Advisor at Mount Sinai Ambulatory Ventures, Inc., and President at Mount Sinai Innovation Partners since 2019.
Dr. Lium's former job(s) include Director at Icahn School of Medicine at Mount Sinai, Director at Amathus Therapeutics, Inc., Director at PreciseDx Ltd., and Assistant Vice Chancellor-Innovation & Technology at The University of California, San Francisco from 2006 to 2014.
Dr. Lium's education history includes an undergraduate degree from Gonzaga University in 1990 and a doctorate degree from Columbia University College of Physicians & Surgeons in 1997.
Postes actifs de Erik Lium
| Sociétés | Poste | Début |
|---|---|---|
| RENALYTIX PLC | Directeur/Membre du Conseil | 01/10/2018 |
| VERICI DX PLC | Directeur/Membre du Conseil | 19/08/2020 |
| TRELLUS HEALTH PLC | Directeur/Membre du Conseil | - |
| ELWC Enterprises Ltd. | Directeur/Membre du Conseil | - |
CastleVax, Inc.
 CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Directeur/Membre du Conseil | - |
Accelerate Long Island (Venture Capital)
 Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Private Equity Investor | 01/04/2017 |
The Mount Sinai Health System, Inc.
 The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/07/2019 |
Kantaro Biosciences LLC
 Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Président | - |
Mount Sinai Innovation Partners
 Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | President | 01/03/2014 |
| ░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
Anciens postes connus de Erik Lium
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Erik Lium
| Columbia University College of Physicians & Surgeons | Doctorate Degree |
| Gonzaga University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| RENALYTIX PLC | Technology Services |
| VERICI DX PLC | Health Services |
| TRELLUS HEALTH PLC | Technology Services |
| Entreprise privées | 10 |
|---|---|
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Health Services |
Amathus Therapeutics, Inc.
 Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Finance |
LabVelocity
 LabVelocity Packaged SoftwareTechnology Services Part of Copyright Clearance Center, Inc., LabVelocity develops scientific software solutions. The company is based in Burlingame, CA. The company was founded by Erik Lium. LabVelocity was acquired by Infotrieve, Inc., part of Copyright Clearance Center, Inc. from November 06, 2014 on October 11, 2004. | Technology Services |
Mount Sinai Innovation Partners
Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | Commercial Services |
Kantaro Biosciences LLC
Kantaro Biosciences LLC Medical SpecialtiesHealth Technology Kantaro Biosciences LLC is a health system venture that provides high-quality diagnostic tests for critical health challenges. The joint venture company is based in New York, NY. The company is dedicated to advancing the care and well-being of people, communities, and society by offering rigorous, results-driven, and reproducible diagnostics. Kantaro specializes in the rapid scale-up of groundbreaking diagnostic innovations and the creation of partnerships to bring these crucial technologies to market. | Health Technology |
| ELWC Enterprises Ltd. | |
PreciseDx Ltd.
 PreciseDx Ltd. Data Processing ServicesTechnology Services PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021. | Technology Services |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island/venture capital/ (Accelerate Long Island (Venture Capital)) is a venture capital subsidiary of Accelerate Long Island, Inc founded in 2016. The firm is headquartered in Melville, New York. | Finance |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Health Technology |
Mount Sinai Ambulatory Ventures, Inc
 Mount Sinai Ambulatory Ventures, Inc Investment ManagersFinance Mount Sinai Ambulatory Ventures, Inc (Mount Sinai Ambulatory Ventures) is a venture capital subsidiary of The Mount Sinai Health System, Inc founded in 2008. The firm is headquartered in New York. | Finance |
